$AAWH
Ascend Wellness Holdings, Inc. Stock $aawh

$aawh Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000162828022005776 Filed on March 11, 2022

Income Statement

Concept	2021 Q4	2021
Revenue	$88.50M	$332.4M
YoY Change		131.25%
Cost Of Revenue	$57.66M	$196.4M
YoY Change		137.16%
Gross Profit	$30.84M	$136.0M
YoY Change		123.22%
Gross Profit Margin	34.84%	40.91%
Selling, General & Admin	$31.57M	$119.6M
YoY Change		118.21%
% of Gross Profit	102.37%	87.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.527M	$22.22M
YoY Change		76.89%
% of Gross Profit	17.92%	16.34%
Operating Expenses	$31.57M	$153.2M
YoY Change		188.65%
Operating Profit	-$731.0K	-$17.20M
YoY Change		-319.24%
Interest Expense	-$7.388M	$63.99M
YoY Change		392.49%
% of Operating Profit
Other Income/Expense, Net	$50.00K	-$63.73M
YoY Change		390.78%
Pretax Income	-$8.069M	-$80.94M
YoY Change		1474.96%
Income Tax	$8.442M	$41.72M
% Of Pretax Income
Net Earnings	-$16.51M	-$122.7M
YoY Change		382.16%
Net Earnings / Revenue	-18.66%	-36.9%
Basic Earnings Per Share		-$0.82
Diluted Earnings Per Share	-$110.5K	-$0.82
COMMON SHARES
Basic Shares Outstanding		149.4M shares
Diluted Shares Outstanding		149.4M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$155.5M	$155.5M
YoY Change		174.96%
Cash & Equivalents	$155.5M	$155.5M	$56.55M
Short-Term Investments
Other Short-Term Assets	$24.83M	$24.83M	$32.60M
YoY Change	-23.83%	-27.28%
Inventory	$65.59M	$65.59M	$29.00M
Prepaid Expenses	$7.508M		$2.311M
Receivables	$7.612M	$7.612M	$6.227M
Other Receivables	$4.500M	$4.500M
Total Short-Term Assets	$258.0M	$258.0M	$134.2M
YoY Change	92.29%	92.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$239.7M	$343.6M	$120.5M
YoY Change	98.82%	67.47%
Goodwill	$42.97M		$22.80M
YoY Change	88.47%		2718.05%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$19.57M	$19.57M	$12.73M
YoY Change	53.7%	29.37%
Total Long-Term Assets	$465.4M	$465.4M	$293.6M
YoY Change	58.54%	58.54%
TOTAL ASSETS
Total Short-Term Assets	$258.0M	$258.0M	$134.2M
Total Long-Term Assets	$465.4M	$465.4M	$293.6M
Total Assets	$723.4M	$723.4M	$427.7M
YoY Change	69.13%	69.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.536M	$5.536M	$7.363M
YoY Change	-24.81%	-24.81%
Accrued Expenses	$14.61M	$14.61M
YoY Change		15.85%
Deferred Revenue	$518.0K		$219.0K
YoY Change	136.53%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$27.94M	$27.94M	$59.33M
YoY Change	-52.91%	-52.91%
Total Short-Term Liabilities	$117.4M	$117.4M	$115.3M
YoY Change	1.83%	1.83%
LONG-TERM LIABILITIES
Long-Term Debt	$230.8M	$230.8M	$152.3M
YoY Change	51.6%	51.6%
Other Long-Term Liabilities	$0.00	$198.7M
YoY Change		27.06%
Total Long-Term Liabilities	$230.8M	$429.6M	$152.3M
YoY Change	51.6%	39.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$117.4M	$117.4M	$115.3M
Total Long-Term Liabilities	$230.8M	$429.6M	$152.3M
Total Liabilities	$547.0M	$547.0M	$424.0M
YoY Change	29.01%	29.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$186.2M		-$63.59M
YoY Change	192.88%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$176.5M	$176.5M	$3.786M
YoY Change
Total Liabilities & Shareholders Equity	$723.4M	$723.4M	$427.7M
YoY Change	69.13%	69.13%

Cashflow Statement

Concept	2021 Q4	2021
OPERATING ACTIVITIES
Net Income	-$16.51M	-$122.7M
YoY Change		382.16%
Depreciation, Depletion And Amortization	$5.527M	$22.22M
YoY Change		76.89%
Cash From Operating Activities	-$19.44M	-$41.74M
YoY Change		595.17%
INVESTING ACTIVITIES
Capital Expenditures	-$17.51M	$88.43M
YoY Change		234.71%
Acquisitions		$23.09M
YoY Change		-11.36%
Other Investing Activities	-$10.17M	-$24.81M
YoY Change		473.39%
Cash From Investing Activities	-$27.67M	-$113.2M
YoY Change		266.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$79.27M
YoY Change		304.61%
Cash From Financing Activities	-1.910M	$252.4M
YoY Change		207.12%
NET CHANGE
Cash From Operating Activities	-19.44M	-$41.74M
Cash From Investing Activities	-27.67M	-$113.2M
Cash From Financing Activities	-1.910M	$252.4M
Net Change In Cash	-49.03M	$97.38M
YoY Change		115.01%
FREE CASH FLOW
Cash From Operating Activities	-$19.44M	-$41.74M
Capital Expenditures	-$17.51M	$88.43M
Free Cash Flow	-$1.934M	-$130.2M
YoY Change		301.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001756390
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	333-254800
CY2021	dei	Entity Registrant Name EntityRegistrantName	ASCEND WELLNESS HOLDINGS, INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-0602006
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	1411 Broadway
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	16th Floor
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10018
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	1431234747	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	258012000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	134178000	USD
CY2021	dei	City Area Code CityAreaCode	646
CY2021	dei	Local Phone Number LocalPhoneNumber	661-7600
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Auditor Firm AuditorFirmId	324
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	32598000	USD
CY2020	dei	Auditor Firm AuditorFirmId	688
CY2021	dei	Auditor Name AuditorName	Macias Gini & O’Connell LLP
CY2021	dei	Auditor Location AuditorLocation	San Francisco, California
CY2020	dei	Auditor Name AuditorName	Marcum LLP
CY2020	dei	Auditor Location AuditorLocation	New York, NY
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	155481000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56547000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1550000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7612000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6227000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	65588000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	28997000	USD
CY2021Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	4500000	USD
CY2020Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	8259000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	24831000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	42967000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	22798000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2395000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	239656000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	120540000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	103958000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84642000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	59271000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	50461000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	19572000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12734000	USD
CY2021Q4	us-gaap	Assets Assets	723436000	USD
CY2020Q4	us-gaap	Assets Assets	427748000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	45454000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	31224000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	197295000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	27940000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	59330000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2665000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2128000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	36184000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	18275000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5152000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4328000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	117395000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	115285000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	230846000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	152277000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	156400000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1423000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	196409000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	546959000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	423962000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Common Unit Issued CommonUnitIssued	0	shares
CY2021Q4	us-gaap	Common Unit Authorized CommonUnitAuthorized	0	shares
CY2021Q4	us-gaap	Common Unit Outstanding CommonUnitOutstanding	0	shares
CY2020Q4	us-gaap	Common Unit Outstanding CommonUnitOutstanding	106082000	shares
CY2020Q4	us-gaap	Common Unit Issued CommonUnitIssued	106082000	shares
CY2021Q4	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	0	USD
CY2020Q4	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	362555000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	67378000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-186249000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63592000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	176477000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	3786000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	723436000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	427748000	USD
CY2021	us-gaap	Revenues Revenues	332381000	USD
CY2020	us-gaap	Revenues Revenues	143732000	USD
CY2019	us-gaap	Revenues Revenues	12032000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	153176000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	82818000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	8744000	USD
CY2021	us-gaap	Gross Profit GrossProfit	135972000	USD
CY2020	us-gaap	Gross Profit GrossProfit	60914000	USD
CY2019	us-gaap	Gross Profit GrossProfit	3288000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	116665000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	53067000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29409000	USD
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	36511000	USD
CY2020	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	USD
CY2019	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	53067000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	29409000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-17204000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	7847000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-122657000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-26121000	USD
CY2021	us-gaap	Interest Expense InterestExpense	63989000	USD
CY2020	us-gaap	Interest Expense InterestExpense	12993000	USD
CY2019	us-gaap	Interest Expense InterestExpense	6477000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	256000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-63733000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-12986000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6454000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80937000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5139000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-32575000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	41720000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18702000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	667000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-23841000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-33242000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1598000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1347000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-122657000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-25439000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-31895000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.82
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.82
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	149434000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	149434000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	149434000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95165000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95165000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95165000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87289000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87289000	shares
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26634000	USD
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	38481000	USD
CY2019	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	263000	USD
CY2019	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	2393000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	311000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-33242000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	34840000	USD
CY2020	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2800000	USD
CY2020	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	10973000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	680000	USD
CY2020	aawh	Adjustments To Members Equity Warrant Issued AdjustmentsToMembersEquityWarrantIssued	280000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-122657000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-23841000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3786000	USD
CY2021	aawh	Stock Issued During Period Value Litigation Settlement StockIssuedDuringPeriodValueLitigationSettlement	27431000	USD
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5935000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	137755000	USD
CY2021	aawh	Stock Issued During Period Value Beneficial Conversion Feature Of Shares Converted StockIssuedDuringPeriodValueBeneficialConversionFeatureOfSharesConverted	27361000	USD
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	3652000	USD
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14502000	USD
CY2021	aawh	Adjustments To Additional Paid In Capital Warrants Repurchased AdjustmentsToAdditionalPaidInCapitalWarrantsRepurchased	4156000	USD
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1012000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	176477000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-122657000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-23841000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-33242000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22219000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12561000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4101000	USD
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1359000	USD
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	872000	USD
CY2019	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	194000	USD
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest	42691000	USD
CY2020	us-gaap	Paid In Kind Interest PaidInKindInterest	5319000	USD
CY2019	us-gaap	Paid In Kind Interest PaidInKindInterest	1522000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	23093000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	680000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	311000	USD
CY2021	aawh	Equity Issued In Litigation Settlement EquityIssuedInLitigationSettlement	27431000	USD
CY2020	aawh	Equity Issued In Litigation Settlement EquityIssuedInLitigationSettlement	0	USD
CY2019	aawh	Equity Issued In Litigation Settlement EquityIssuedInLitigationSettlement	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3636000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1286000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1109000	USD
CY2019	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	3664000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	6831000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-605000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-286000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1345000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6007000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	220000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	36500000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11744000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15789000	USD
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	14390000	USD
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	2784000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	5078000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1739000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6729000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1937000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5863000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40929000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	88428000	USD
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	771000	USD
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	3719000	USD
CY2019	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	609000	USD
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	814000	USD
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	2862000	USD
CY2019	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	459000	USD
CY2021	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	17909000	USD
CY2020	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	16500000	USD
CY2019	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	1775000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-41738000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6004000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	26419000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	41670000	USD
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	2976000	USD
CY2020	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	5559000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	23086000	USD
CY2019	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	9200000	USD
CY2021	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	327000	USD
CY2020	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	527000	USD
CY2019	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	USD
CY2021	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	930000	USD
CY2020	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	26750000	USD
CY2019	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	13750000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	26044000	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	8731000	USD
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	127000	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	19700000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-113233000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30872000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-65551000	USD
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	86065000	USD
CY2020	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2019	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	259500000	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	101886000	USD
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	64742000	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	79267000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	19591000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6018000	USD
CY2021	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	4156000	USD
CY2020	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	0	USD
CY2019	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	38481000	USD
CY2021	aawh	Finance Lease Proceeds FinanceLeaseProceeds	0	USD
CY2020	aawh	Finance Lease Proceeds FinanceLeaseProceeds	3750000	USD
CY2019	aawh	Finance Lease Proceeds FinanceLeaseProceeds	14000000	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	478000	USD
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	143000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	8775000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3399000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1012000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	252355000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	82168000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	111062000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	97384000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	45292000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4582000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58097000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12805000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8223000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155481000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58097000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12805000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	20538000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	6204000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	3229000	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	28055000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	2417000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	15682000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	11572000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3435000	USD
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	70660000	USD
CY2020	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2019	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2021	aawh	Convertible Preferred Stock Beneficial Conversion Feature ConvertiblePreferredStockBeneficialConversionFeature	27361000	USD
CY2020	aawh	Convertible Preferred Stock Beneficial Conversion Feature ConvertiblePreferredStockBeneficialConversionFeature	0	USD
CY2019	aawh	Convertible Preferred Stock Beneficial Conversion Feature ConvertiblePreferredStockBeneficialConversionFeature	0	USD
CY2021	aawh	Noncash Or Part Noncash Acquisition Value Of Shares Issued For Acquisition NoncashOrPartNoncashAcquisitionValueOfSharesIssuedForAcquisition	3652000	USD
CY2020	aawh	Noncash Or Part Noncash Acquisition Value Of Shares Issued For Acquisition NoncashOrPartNoncashAcquisitionValueOfSharesIssuedForAcquisition	2319000	USD
CY2019	aawh	Noncash Or Part Noncash Acquisition Value Of Shares Issued For Acquisition NoncashOrPartNoncashAcquisitionValueOfSharesIssuedForAcquisition	0	USD
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	USD
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	481000	USD
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	263000	USD
CY2021	aawh	Noncash Or Part Noncash Acquisition Value Of Shares Issued For Noncontrolling Interest NoncashOrPartNoncashAcquisitionValueOfSharesIssuedForNoncontrollingInterest	0	USD
CY2020	aawh	Noncash Or Part Noncash Acquisition Value Of Shares Issued For Noncontrolling Interest NoncashOrPartNoncashAcquisitionValueOfSharesIssuedForNoncontrollingInterest	1018000	USD
CY2019	aawh	Noncash Or Part Noncash Acquisition Value Of Shares Issued For Noncontrolling Interest NoncashOrPartNoncashAcquisitionValueOfSharesIssuedForNoncontrollingInterest	0	USD
CY2021	aawh	Warrants Issued During Issuance Of Notes Payable WarrantsIssuedDuringIssuanceOfNotesPayable	0	USD
CY2020	aawh	Warrants Issued During Issuance Of Notes Payable WarrantsIssuedDuringIssuanceOfNotesPayable	280000	USD
CY2019	aawh	Warrants Issued During Issuance Of Notes Payable WarrantsIssuedDuringIssuanceOfNotesPayable	0	USD
CY2021	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	0	USD
CY2020	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	0	USD
CY2019	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	2393000	USD
CY2021	us-gaap	Nature Of Operations NatureOfOperations	THE COMPANY AND NATURE OF OPERATIONS<div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ascend Wellness Holdings, Inc., which operates through its subsidiaries (collectively referred to as “AWH,” “Ascend,” “we,” “us,” “our,” or the “Company”), is a multi-state operator in the United States cannabis industry. AWH owns, manages, and operates cannabis cultivation facilities and dispensaries in several states across the United States, including Illinois, Massachusetts, Michigan, New Jersey, and Ohio. AWH is headquartered in New York, New York.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was originally formed on May 15, 2018 as Ascend Group Partners, LLC, and changed its name to “Ascend Wellness Holdings, LLC” on September 10, 2018. On April 22, 2021, Ascend Wellness Holdings, LLC converted into a Delaware corporation and changed its name to “Ascend Wellness Holdings, Inc.” and effected a 2-for-1 reverse stock split (the “Reverse Split”), which is retrospectively presented for all periods in these financial statements. We refer to this conversion throughout this filing as the “Conversion.” As a result of the Conversion, the members of Ascend Wellness Holdings, LLC became holders of shares of stock of Ascend Wellness Holdings, Inc. Following the Conversion, the Company has authorized 750,000 shares of Class A common stock with a par value of $0.001 per share, 100 shares of Class B common stock with a par value of $0.001 per share, and 10,000 shares of preferred stock with a par value of $0.001 per share. The historical consolidated financial statements prior to the Conversion date are those of Ascend Wellness Holdings, LLC and its subsidiaries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights of the holders of Class A common stock and Class B common stock are identical, except for voting and conversion rights. Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is entitled to 1,000 votes per share and is convertible at any time into one share of Class A common stock at the option of the holder. See Note 12, “Stockholders’ Equity,” for additional details.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Initial Public Offering</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 4, 2021, the Company completed an Initial Public Offering (“IPO”) of its Class A common stock, in which it issued and sold 10,000 shares of Class A common stock at a price of $8.00 per share. On May 7, 2021, the underwriters exercised their over-allotment option in full and we issued and sold an additional 1,500 shares of Class A common stock. We received total net proceeds of approximately $86,065 after deducting underwriting discounts and commissions and certain other direct offering expenses paid by us. In connection with the IPO, the historical common units, Series Seed Preferred Units, Series Seed+ Preferred Units, and Real Estate Preferred Units then-outstanding automatically converted into a total of 113,301 shares of Class A common stock and 65 historical common units were allocated as shares of Class B common stock. Additionally, 3,420 shares of Class A common stock were issued for a beneficial conversion feature associated with the conversion of certain historical preferred units and the Company’s convertible notes, plus accrued interest, converted into 37,388 shares of Class A common stock. See Note 12, “Stockholders’ Equity,” for additional details.</span></div>Shares of the Company’s Class A common stock are listed on the Canadian Securities Exchange (the “CSE”) under the ticker symbol “AAWH.U” and are quoted on the OTCQX Best Market (the “OTCQX”) under the symbol “AAWH.” We are an emerging growth company under federal securities laws and as such we are able to elect to follow scaled disclosure requirements for this filing.
CY2021Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	2
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts. We base our estimates on historical experience, known or expected trends, independent valuations, and various other measurements that we believe to be reasonable under the circumstances. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.</span></div>
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with our current period presentation. These changes had no impact on our previously reported net loss.</span></div>
CY2020Q4	us-gaap	Minority Interest MinorityInterest	0	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	155481000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56547000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1550000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155481000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58097000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	374000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2020	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2019	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	518000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	219000	USD
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11513000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	37181000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12146000	shares
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021	us-gaap	Revenues Revenues	332381000	USD
CY2020	us-gaap	Revenues Revenues	143732000	USD
CY2019	us-gaap	Revenues Revenues	12032000	USD
CY2021	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y
CY2020	us-gaap	Revenues Revenues	143732000	USD
CY2020	aawh	Business Acquisition Pro Forma Revenue Adjustments BusinessAcquisitionProFormaRevenueAdjustments	0	USD
CY2020	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	165809000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-23841000	USD
CY2020	aawh	Business Acquisition Pro Forma Net Income Loss Adjustments BusinessAcquisitionProFormaNetIncomeLossAdjustments	-10897000	USD
CY2020	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-30346000	USD
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	8899000	USD
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	7756000	USD
CY2020	aawh	Business Acquisition Pro Forma Amortization Of Intangible Assets BusinessAcquisitionProFormaAmortizationOfIntangibleAssets	2879000	USD
CY2020	aawh	Business Acquisition Pro Forma Interest Expense Debt BusinessAcquisitionProFormaInterestExpenseDebt	8544000	USD
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	526000	USD
CY2019	us-gaap	Revenues Revenues	12032000	USD
CY2019	aawh	Business Acquisition Pro Forma Revenue Adjustments BusinessAcquisitionProFormaRevenueAdjustments	0	USD
CY2019	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	26942000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-33242000	USD
CY2019	aawh	Business Acquisition Pro Forma Net Income Loss Adjustments BusinessAcquisitionProFormaNetIncomeLossAdjustments	-15337000	USD
CY2019	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-47083000	USD
CY2019	aawh	Business Acquisition Pro Forma Amortization Of Intangible Assets BusinessAcquisitionProFormaAmortizationOfIntangibleAssets	3971000	USD
CY2019	aawh	Business Acquisition Pro Forma Interest Expense Debt BusinessAcquisitionProFormaInterestExpenseDebt	11366000	USD
CY2021Q4	us-gaap	Other Inventory Capitalized Costs OtherInventoryCapitalizedCosts	8571000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	28235000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	13615000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	28454000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7626000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	65588000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	28997000	USD
CY2021	aawh	Compensation Costs Capitalized During The Period CompensationCostsCapitalizedDuringThePeriod	35663000	USD
CY2020	aawh	Compensation Costs Capitalized During The Period CompensationCostsCapitalizedDuringThePeriod	15588000	USD
CY2019	aawh	Compensation Costs Capitalized During The Period CompensationCostsCapitalizedDuringThePeriod	1918000	USD
CY2020Q4	us-gaap	Other Inventory Capitalized Costs OtherInventoryCapitalizedCosts	5909000	USD
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	4500000	USD
CY2020Q4	us-gaap	Notes Receivable Net NotesReceivableNet	8259000	USD
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2020	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2019	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	260985000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	127079000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21329000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6539000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	239656000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	120540000	USD
CY2021	us-gaap	Depreciation Depreciation	14807000	USD
CY2020	us-gaap	Depreciation Depreciation	5030000	USD
CY2019	us-gaap	Depreciation Depreciation	1509000	USD
CY2021	aawh	Inventory Depreciation Capitalized During The Period InventoryDepreciationCapitalizedDuringThePeriod	10120000	USD
CY2020	aawh	Inventory Depreciation Capitalized During The Period InventoryDepreciationCapitalizedDuringThePeriod	4297000	USD
CY2019	aawh	Inventory Depreciation Capitalized During The Period InventoryDepreciationCapitalizedDuringThePeriod	589000	USD
CY2021Q4	aawh	Inventory Capitalized Depreciation InventoryCapitalizedDepreciation	2070000	USD
CY2020Q4	aawh	Inventory Capitalized Depreciation InventoryCapitalizedDepreciation	602000	USD
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-664000	USD
CY2021	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	17000	USD
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	75624000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	60061000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16353000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9600000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	59271000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	50461000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6753000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7531000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2069000	USD
CY2021	aawh	Inventory Amortization Capitalized During The Period InventoryAmortizationCapitalizedDuringThePeriod	1404000	USD
CY2020	aawh	Inventory Amortization Capitalized During The Period InventoryAmortizationCapitalizedDuringThePeriod	350000	USD
CY2019	aawh	Inventory Amortization Capitalized During The Period InventoryAmortizationCapitalizedDuringThePeriod	0	USD
CY2021Q4	aawh	Inventory Capitalized Amortization InventoryCapitalizedAmortization	502000	USD
CY2020Q4	aawh	Inventory Capitalized Amortization InventoryCapitalizedAmortization	564000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	6304000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	6304000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7724000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7724000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	6853000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	809000	USD
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	21989000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	22798000	USD
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	11042000	USD
CY2021	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	9127000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	42967000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	103958000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84642000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2665000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2128000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	197295000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	156400000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	199960000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	158528000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	24663000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	16603000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	5828000	USD
CY2021Q4	aawh	Inventory Lease Costs Capitalized InventoryLeaseCostsCapitalized	4393000	USD
CY2020Q4	aawh	Inventory Lease Costs Capitalized InventoryLeaseCostsCapitalized	4913000	USD
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	59000	USD
CY2021	aawh	Number Of Leases Terminated NumberOfLeasesTerminated	2	lease
CY2021	aawh	Short Term Lease And Variable Lease Cost ShortTermLeaseAndVariableLeaseCost	2540000	USD
CY2020	aawh	Short Term Lease And Variable Lease Cost ShortTermLeaseAndVariableLeaseCost	2615000	USD
CY2019	aawh	Short Term Lease And Variable Lease Cost ShortTermLeaseAndVariableLeaseCost	735000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	22439000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	12895000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	5172000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	41917000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	91367000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	45108000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P15Y9M18D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P17Y3M18D
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	29005000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	347109000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	485702000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.127
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.131
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	26224000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	27007000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	27780000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	28577000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	285742000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	199960000	USD
CY2021Q4	aawh	Financing Liability To Be Paid Year One FinancingLiabilityToBePaidYearOne	2082000	USD
CY2021Q4	aawh	Financing Liability To Be Paid Year Two FinancingLiabilityToBePaidYearTwo	2143000	USD
CY2021Q4	aawh	Financing Liability To Be Paid Year Three FinancingLiabilityToBePaidYearThree	2206000	USD
CY2021Q4	aawh	Financing Liability To Be Paid Year Four FinancingLiabilityToBePaidYearFour	2271000	USD
CY2021Q4	aawh	Financing Liability To Be Paid Year Five FinancingLiabilityToBePaidYearFive	2338000	USD
CY2021Q4	aawh	Financing Liability To Be Paid After Year Five FinancingLiabilityToBePaidAfterYearFive	6811000	USD
CY2021Q4	aawh	Financing Liability FinancingLiability	17851000	USD
CY2021Q2	aawh	Sale Leaseback Transaction Expected Purchase Price SaleLeasebackTransactionExpectedPurchasePrice	350000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3750000	USD
CY2020Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	26750000	USD
CY2020Q2	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	-286000	USD
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	55287000	USD
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33037000	USD
CY2020Q2	us-gaap	Incentive To Lessee IncentiveToLessee	22250000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	266866000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	215029000	USD
CY2021Q4	aawh	Long Term Debt Current Maturities Gross LongTermDebtCurrentMaturitiesGross	27980000	USD
CY2020Q4	aawh	Long Term Debt Current Maturities Gross LongTermDebtCurrentMaturitiesGross	60357000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	40000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	1027000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	27940000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	59330000	USD
CY2021Q4	aawh	Long Term Debt Excluding Current Maturities Gross LongTermDebtExcludingCurrentMaturitiesGross	238886000	USD
CY2020Q4	aawh	Long Term Debt Excluding Current Maturities Gross LongTermDebtExcludingCurrentMaturitiesGross	154672000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	8040000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	2395000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	230846000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	152277000	USD
CY2019Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.00
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	17638000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	6204000	USD
CY2019	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3229000	USD
CY2021	aawh	Amortization Of Debt Discount And Non Cash Interest Expense AmortizationOfDebtDiscountAndNonCashInterestExpense	9710000	USD
CY2020	aawh	Amortization Of Debt Discount And Non Cash Interest Expense AmortizationOfDebtDiscountAndNonCashInterestExpense	5398000	USD
CY2019	aawh	Amortization Of Debt Discount And Non Cash Interest Expense AmortizationOfDebtDiscountAndNonCashInterestExpense	2832000	USD
CY2021	aawh	Interest Expense Beneficial Conversion Feature Non Cash InterestExpenseBeneficialConversionFeatureNonCash	27361000	USD
CY2020	aawh	Interest Expense Beneficial Conversion Feature Non Cash InterestExpenseBeneficialConversionFeatureNonCash	0	USD
CY2019	aawh	Interest Expense Beneficial Conversion Feature Non Cash InterestExpenseBeneficialConversionFeatureNonCash	0	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-6637000	USD
CY2021	aawh	Interest On Financing Liability InterestOnFinancingLiability	2643000	USD
CY2020	aawh	Interest On Financing Liability InterestOnFinancingLiability	1391000	USD
CY2019	aawh	Interest On Financing Liability InterestOnFinancingLiability	416000	USD
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	63989000	USD
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	12993000	USD
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	6477000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	-1656000	USD
CY2021	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	4981000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Shares Outstanding SharesOutstanding	171586000	shares
CY2021Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2021Q4	aawh	Restricted Stock No Par Value RestrictedStockNoParValue	0
CY2021Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2020Q4	us-gaap	Common Unit Outstanding CommonUnitOutstanding	106082000	shares
CY2021Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1986000	shares
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2168000	shares
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.60
CY2019	aawh	Class Of Warrant Or Right Weighted Average Remaining Exercise Period ClassOfWarrantOrRightWeightedAverageRemainingExercisePeriod	P2Y
CY2019Q4	aawh	Class Of Warrant Or Right Intrinsic Value Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightIntrinsicValueExercisePriceOfWarrantsOrRights	0	USD
CY2020	aawh	Class Of Warrant Or Right Granted ClassOfWarrantOrRightGranted	2457000	shares
CY2020	aawh	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Granted ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsGranted	4.00
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4625000	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.81
CY2020	aawh	Class Of Warrant Or Right Weighted Average Remaining Exercise Period ClassOfWarrantOrRightWeightedAverageRemainingExercisePeriod	P2Y4M24D
CY2020Q4	aawh	Class Of Warrant Or Right Intrinsic Value Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightIntrinsicValueExercisePriceOfWarrantsOrRights	0	USD
CY2021	aawh	Class Of Warrant Or Right Cancelled ClassOfWarrantOrRightCancelled	1094000	shares
CY2021	aawh	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Cancelled ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsCancelled	3.20
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3531000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.00
CY2021	aawh	Class Of Warrant Or Right Weighted Average Remaining Exercise Period ClassOfWarrantOrRightWeightedAverageRemainingExercisePeriod	P2Y
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80937000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5139000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-32575000	USD
CY2021Q4	aawh	Class Of Warrant Or Right Intrinsic Value Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightIntrinsicValueExercisePriceOfWarrantsOrRights	9216000	USD
CY2021Q4	aawh	Class Of Warrant Or Right Estimated Grant Date Fair Value ClassOfWarrantOrRightEstimatedGrantDateFairValue	237000	USD
CY2021	aawh	Share Based Compensation Arrangement By Share Based Payment Award Restricted Award Exercise Period Following Ipo ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardExercisePeriodFollowingIPO	P6M
CY2021Q4	aawh	Share Based Compensation Arrangement By Share Based Payment Award Options Ownership Percentage To Trigger Increased Exercise Price Requirement ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOwnershipPercentageToTriggerIncreasedExercisePriceRequirement	0.10
CY2021Q4	aawh	Share Based Compensation Arrangement By Share Based Payment Award Options Minimum Exercise Price As A Percentage Of Closing Market Value Of Stock If Ownership Percentage Exceeds Threshold ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMinimumExercisePriceAsAPercentageOfClosingMarketValueOfStockIfOwnershipPercentageExceedsThreshold	1.10
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	31747000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	13879000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1230000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	13609000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	6109000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	551000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2502000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-922000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-502000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1134000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-364000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-612000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	41720000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18702000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	667000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-16997000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1079000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6841000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	12475000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	5745000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-62000	USD
CY2021	aawh	Effective Income Tax Rate Reconciliation Expenses Disallowed Under Irc280 E EffectiveIncomeTaxRateReconciliationExpensesDisallowedUnderIRC280E	31510000	USD
CY2020	aawh	Effective Income Tax Rate Reconciliation Expenses Disallowed Under Irc280 E EffectiveIncomeTaxRateReconciliationExpensesDisallowedUnderIRC280E	13729000	USD
CY2019	aawh	Effective Income Tax Rate Reconciliation Expenses Disallowed Under Irc280 E EffectiveIncomeTaxRateReconciliationExpensesDisallowedUnderIRC280E	4665000	USD
CY2021	aawh	Effective Income Tax Rate Reconciliation Nondeductible Expense Litigation Settlement EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement	7667000	USD
CY2020	aawh	Effective Income Tax Rate Reconciliation Nondeductible Expense Litigation Settlement EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement	0	USD
CY2019	aawh	Effective Income Tax Rate Reconciliation Nondeductible Expense Litigation Settlement EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement	0	USD
CY2021	aawh	Effective Income Tax Rate Reconciliation Nondeductible Ipo Interest Related Expense EffectiveIncomeTaxRateReconciliationNondeductibleIPOInterestRelatedExpense	5746000	USD
CY2020	aawh	Effective Income Tax Rate Reconciliation Nondeductible Ipo Interest Related Expense EffectiveIncomeTaxRateReconciliationNondeductibleIPOInterestRelatedExpense	0	USD
CY2019	aawh	Effective Income Tax Rate Reconciliation Nondeductible Ipo Interest Related Expense EffectiveIncomeTaxRateReconciliationNondeductibleIPOInterestRelatedExpense	0	USD
CY2021	aawh	Effective Income Tax Rate Reconciliation Other Permanent Differences EffectiveIncomeTaxRateReconciliationOtherPermanentDifferences	1395000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	667000	USD
CY2020	aawh	Effective Income Tax Rate Reconciliation Other Permanent Differences EffectiveIncomeTaxRateReconciliationOtherPermanentDifferences	261000	USD
CY2019	aawh	Effective Income Tax Rate Reconciliation Other Permanent Differences EffectiveIncomeTaxRateReconciliationOtherPermanentDifferences	106000	USD
CY2021	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	0	USD
CY2020	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	-46000	USD
CY2019	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	-2799000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-76000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	0	USD
CY2019	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	41720000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18702000	USD
CY2021Q4	aawh	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	50089000	USD
CY2020Q4	aawh	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	40543000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	284000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	193000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	51669000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	801000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	337000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	370000	USD
CY2021Q4	aawh	Deferred Tax Assets Loyalty Program DeferredTaxAssetsLoyaltyProgram	158000	USD
CY2020Q4	aawh	Deferred Tax Assets Loyalty Program DeferredTaxAssetsLoyaltyProgram	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	51669000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	41106000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	41106000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	21344000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	19129000	USD
CY2021Q4	aawh	Deferred Tax Liabilities Tenant Improvement Allowance DeferredTaxLiabilitiesTenantImprovementAllowance	764000	USD
CY2020Q4	aawh	Deferred Tax Liabilities Tenant Improvement Allowance DeferredTaxLiabilitiesTenantImprovementAllowance	7197000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	24200000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	12385000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	6784000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	0	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	53092000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	38711000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1423000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2395000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2019	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	USD
CY2021	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	USD
CY2020	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	USD
CY2021Q4	us-gaap	Income Tax Examination Interest Accrued IncomeTaxExaminationInterestAccrued	0	USD
CY2020Q4	us-gaap	Income Tax Examination Interest Accrued IncomeTaxExaminationInterestAccrued	0	USD
CY2021Q4	aawh	Supply Agreement Percentage Of Gross Monthly Sales For Initial Term SupplyAgreementPercentageOfGrossMonthlySalesForInitialTerm	0.075
	aawh	Supply Agreement Initial Term SupplyAgreementInitialTerm	P5Y
	aawh	Supply Agreement Percentage Of Gross Monthly Sales After Initial Term SupplyAgreementPercentageOfGrossMonthlySalesAfterInitialTerm	0.05
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7508000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2311000	USD
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	5177000	USD
CY2020Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	4021000	USD
CY2021Q4	aawh	Construction Deposits Current ConstructionDepositsCurrent	3263000	USD
CY2020Q4	aawh	Construction Deposits Current ConstructionDepositsCurrent	712000	USD
CY2021Q4	aawh	Tenant Improvement Allowance Current TenantImprovementAllowanceCurrent	2507000	USD
CY2020Q4	aawh	Tenant Improvement Allowance Current TenantImprovementAllowanceCurrent	24349000	USD
CY2021Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	6376000	USD
CY2020Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	1205000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	24831000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	32598000	USD
CY2021Q4	aawh	Accrued Capital Expenditures AccruedCapitalExpenditures	15682000	USD
CY2020Q4	aawh	Accrued Capital Expenditures AccruedCapitalExpenditures	11572000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	11760000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2762000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5536000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7363000	USD
CY2021Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	5480000	USD
CY2020Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	0	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	187000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	7723000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6809000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1804000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	45454000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	31224000	USD
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	55773000	USD
CY2020	us-gaap	Labor And Related Expense LaborAndRelatedExpense	15986000	USD
CY2019	us-gaap	Labor And Related Expense LaborAndRelatedExpense	8831000	USD
CY2021	us-gaap	Occupancy Net OccupancyNet	18993000	USD
CY2020	us-gaap	Occupancy Net OccupancyNet	14631000	USD
CY2019	us-gaap	Occupancy Net OccupancyNet	6758000	USD
CY2021	us-gaap	Professional Fees ProfessionalFees	16057000	USD
CY2020	us-gaap	Professional Fees ProfessionalFees	9325000	USD
CY2019	us-gaap	Professional Fees ProfessionalFees	6692000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10036000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7914000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3578000	USD
CY2021	us-gaap	General Insurance Expense GeneralInsuranceExpense	5126000	USD
CY2020	us-gaap	General Insurance Expense GeneralInsuranceExpense	1467000	USD
CY2019	us-gaap	General Insurance Expense GeneralInsuranceExpense	758000	USD
CY2021	us-gaap	Marketing Expense MarketingExpense	2968000	USD
CY2020	us-gaap	Marketing Expense MarketingExpense	1758000	USD
CY2019	us-gaap	Marketing Expense MarketingExpense	1213000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-605000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-286000	USD
CY2020	us-gaap	Other General Expense OtherGeneralExpense	1700000	USD
CY2019	us-gaap	Other General Expense OtherGeneralExpense	1579000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	116665000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2021	us-gaap	Other General Expense OtherGeneralExpense	7107000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	53067000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29409000	USD

Files In Submission

Name	View Source	Status
0001628280-22-005776-index-headers.html	Edgar Link	pending
0001628280-22-005776-index.html	Edgar Link	pending
0001628280-22-005776.txt	Edgar Link	pending
0001628280-22-005776-xbrl.zip	Edgar Link	pending
aawh-20211231.htm	Edgar Link	pending
aawh-20211231.xsd	Edgar Link	pending
aawh-20211231_cal.xml	Edgar Link	unprocessable
aawh-20211231_def.xml	Edgar Link	unprocessable
aawh-20211231_g1.jpg	Edgar Link	pending
aawh-20211231_g2.jpg	Edgar Link	pending
aawh-20211231_g3.jpg	Edgar Link	pending
aawh-20211231_g4.jpg	Edgar Link	pending
aawh-20211231_g5.jpg	Edgar Link	pending
aawh-20211231_g6.jpg	Edgar Link	pending
aawh-20211231_g7.jpg	Edgar Link	pending
aawh-20211231_htm.xml	Edgar Link	completed
aawh-20211231_lab.xml	Edgar Link	unprocessable
aawh-20211231_pre.xml	Edgar Link	unprocessable
awh12312021exhibit1013.htm	Edgar Link	pending
awh12312021exhibit211.htm	Edgar Link	pending
awh12312021exhibit231.htm	Edgar Link	pending
awh12312021exhibit232.htm	Edgar Link	pending
awh12312021exhibit311.htm	Edgar Link	pending
awh12312021exhibit312.htm	Edgar Link	pending
awh12312021exhibit32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mgoa.jpg	Edgar Link	pending
mgofooter1.jpg	Edgar Link	pending
mgofooter2.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AAWH
Ascend Wellness Holdings, Inc. Stock $aawh

2021 Q4 Form 10-K Financial Statement

#000162828022005776 Filed on March 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AAWH Ascend Wellness Holdings, Inc. Stock $aawh

2021 Q4 Form 10-K Financial Statement

#000162828022005776 Filed on March 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AAWH
Ascend Wellness Holdings, Inc. Stock $aawh